Dept. of Pathology of IRCCS Istituto Ortopedico Rizzoli
Bologna, Italy
Orthopedic clinic in Bologna
Via Giulio Cesare Pupilli, 1, 40136 Bologna BO
About Dept. of Pathology of IRCCS Istituto Ortopedico Rizzoli
"Istituto Ortopedico"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Dept. of Pathology of IRCCS Istituto Ortopedico Rizzoli
During the past decade, Dept. of Pathology of IRCCS Istituto Ortopedico Rizzoli conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Inflammatory Bowel Disease
2015-04-22
2018-10-31
Completed
2,565
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
2018-04-13
2030-06-30
Active, not recruiting
1,409
Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis
2019-06-13
2022-02-16
Completed
433
An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis
2019-09-05
2027-01-31
Recruiting
900
Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis
2020-09-15
2021-12-07
Completed
354
Etrasimod Versus Placebo for the Treatment of Moderately Active Ulcerative Colitis
2021-04-12
2025-01-31
Recruiting
225
A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease
2022-01-19
2025-08-14
Recruiting
318
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease
2022-07-22
2030-10-08
Recruiting
715
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Dept. of Pathology of IRCCS Istituto Ortopedico Rizzoli
According to Clinical.Site data, the most researched conditions in "Dept. of Pathology of IRCCS Istituto Ortopedico Rizzoli" are
"Ewing Sarcoma of Bone" (1 trials) and "Osteofibrous Dysplasia" (1 trials). Many other conditions were trialed in "Dept. of Pathology of IRCCS Istituto Ortopedico Rizzoli" in a lesser frequency.
Clinical Trials Intervention Types at Dept. of Pathology of IRCCS Istituto Ortopedico Rizzoli
Most popular intervention types in "Dept. of Pathology of IRCCS Istituto Ortopedico Rizzoli" are "Behavioral" (2 trials). Other intervention types were less common.
The name of intervention was led by "Scoring tool in Chemotherapy-induced necrosis in Ewing sarcoma" (1 trials) and "study of osteofibrous dysplasia features" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Dept. of Pathology of IRCCS Istituto Ortopedico Rizzoli
The vast majority of trials in "Dept. of Pathology of IRCCS Istituto Ortopedico Rizzoli" are
2 trials for "All" genders.
Clinical Trials Status at Dept. of Pathology of IRCCS Istituto Ortopedico Rizzoli
Currently, there are NaN active trials in "Dept. of Pathology of IRCCS Istituto Ortopedico Rizzoli".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Dept. of Pathology of IRCCS Istituto Ortopedico Rizzoli,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Dept. of Pathology of IRCCS Istituto Ortopedico Rizzoli, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".